Skip to content


Kuvan (sapropterin) is a small molecule pharmaceutical. Sapropterin was first approved as Kuvan on 2007-12-13. It is used to treat phenylketonurias in the USA. It has been approved in Europe to treat phenylketonurias. The pharmaceutical is active against phenylalanine-4-hydroxylase. Kuvan's patents are valid until 2032-11-01 (FDA).
Trade Name Kuvan
Common Name Sapropterin
Indication phenylketonurias
Drug Class
Get full access now